k.karlsen
TL2 · Malmö
Contributes reviews on supplier material. Based in Malmö.
Joined 26 December 2024 · last posted 11h
81 posts, newest first. Showing up to 150.
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #35 · Lounge › Off topic · 27 Jul 2026 · 4 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #94 · Practice › Interactions · 26 Jul 2026 · 4 likes I read post #92 twice before replying, because I had assumed the opposite. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #55 · Practice › Dosing & titration · 11 Jul 2026 · 26 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #25 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 17 likes On post #23 — agreed on the reasoning, with one qualification. Reading this Reading a rodent study thread as someone who came in with a fixed view: the third and…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #37 · Research Methods › Statistics · 28 Jun 2026 · 0 likes Building on post #36 rather than restating it. Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help…
-
Restarting after a long gap: what the labelling implies Replied, post #4 · Practice › Dosing & titration · 28 Jun 2026 · 0 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
-
Follow-up: Reading an interaction checker output critically Replied, post #18 · Practice › Interactions · 25 Jun 2026 · 15 likes Worth separating two things that post #14 runs together. Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about…
-
Injecting into an area that has become firm: why not to Replied, post #23 · Practice › Administration · 6 Jun 2026 · 25 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #28 · Sourcing › Red flags · 3 Jun 2026 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #64 · Practice › Reconstitution · 30 May 2026 · 12 likes Post #61 answers the question as asked. The question underneath it is different. Worked example, since the arithmetic is the whole question. Five milligrams into one…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #68 · Evidence › Journal club · 20 May 2026 · 7 likes This follows post #65 rather than contradicting it. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that…
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #12 · Compounds › Retatrutide · 16 May 2026 · 0 likes Post #9 and I disagree about the size of the effect, not about the direction. No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #55 · Compounds › Semaglutide · 13 May 2026 · 13 likes Post #52 answers the question as asked. The question underneath it is different. Discontinuation rates in the trials are worth reading alongside efficacy and almost…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #21 · Compounds › Semaglutide · 9 May 2026 · 18 likes Adding the measurement that post #18 says would settle it. Filing a mild objection to the consensus on semaglutide and gastric emptying. Mild because I might be wrong;…
-
Citation sweep results: how many references did not say what was claimed Replied, post #87 · Meta › Wiki maintenance · 1 May 2026 · 0 likes Post #85 is right about the mechanism and I think understates the practical bit. That matches how I use it. The general statement is what you check afterwards, not what…
-
Publication bias detection and its low power — does this still hold? Replied, post #27 · Evidence › Meta-analyses · 30 Apr 2026 · 0 likes My understanding of Publication bias detection is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #99 · Practice › Interactions · 24 Apr 2026 · 21 likes Good question, well framed, and I would like to see it answered properly.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #58 · Evidence › Trials · 24 Apr 2026 · 12 likes Answering the Subgroup analyses question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
-
Revisiting: Mobile reading experience on long topics Replied, post #3 · Meta › Site feedback · 18 Apr 2026 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. That is a fair objection and it changes my view. Better to leave topics…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #60 · Analytics › Mass spectrometry · 6 Apr 2026 · 15 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #67 · Practice › Dosing & titration · 2 Mar 2026 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #53 · Practice › Storage & stability · 2 Mar 2026 · 18 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I would be interested in a…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #77 · Evidence › Study critique · 22 Feb 2026 · 1 like Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #10 · Analytics › Impurities & related substances · 20 Feb 2026 · 18 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #46 · Regional › UK & Ireland · 18 Feb 2026 · 29 likes Reframing pharmacy supply slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #46 · Practice › Side effects · 15 Feb 2026 · 19 likes The confident answers on Dizziness on standing and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #59 · Sourcing › Regulatory · 14 Feb 2026 · 3 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
[2026 update] Hello from a laboratory that does not do peptides Replied, post #2 · Lounge › Introductions · 3 Jan 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #17 · Practice › Side effects · 2 Jan 2026 · 6 likes Gastrointestinal effects in this class are dose-related and escalation-related. Both are true simultaneously, which is why symptoms typically return at each step and…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #17 · Sourcing › Vendor reports · 29 Dec 2025 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. The right answer here may simply be that it has not…
-
Comparing my trajectory with the trial curves, carefully Replied, post #78 · Outcomes › Progress reports · 19 Nov 2025 · 0 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Long-time reader, first-time poster Replied, post #11 · Lounge › Introductions · 10 Nov 2025 · 11 likes Summarising the long-time reader thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Why "add 2 mL" is not an instruction Replied, post #4 · Practice › Reconstitution · 31 Oct 2025 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #81 · Start Here › Welcome · 20 Oct 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #28 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #62 · Start Here › Welcome · 18 Oct 2025 · 21 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Compounds this community declines to help with, and why Replied, post #40 · Compounds › Other compounds · 1 Oct 2025 · 18 likes Worth separating two things that post #36 runs together. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #77 · Practice › Administration · 24 Sep 2025 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
What this community means by "a source", in practical terms Replied, post #103 · Start Here › Welcome · 7 Sep 2025 · 30 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Started this topic · Practice › Storage & stability · 7 Sep 2025 · 11 likes Storing lyophilised material long term: what governs the shelf life — setting out what I have, and where I think it stops being reliable. Two things I would like…
-
Are there stupid questions here? A staff answer, at length Replied, post #153 · Start Here › Welcome · 5 Sep 2025 · 30 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #44 · Practice › Storage & stability · 3 Sep 2025 · 2 likes The claim about power cut for eleven hours upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Lyophilisation and why the cake looks the way it does Replied, post #14 · Pharmacology › Formulation chemistry · 31 Aug 2025 · 31 likes Adding the measurement that post #12 says would settle it. Small correction to my own earlier position on lyophilisation. I had the units the wrong way round, which…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #54 · Practice › Side effects · 26 Aug 2025 · 16 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Immortal time bias in a claims-database study Replied, post #26 · Evidence › Study critique · 21 Aug 2025 · 28 likes Taking post #23 at face value and following it one step further. Immortal time bias has a well-known answer and a correct answer, and the interesting work is…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #35 · Analytics › HPLC & UHPLC · 19 Aug 2025 · 2 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
-
A ten-fold dose error caught before injection — one year on Replied, post #66 · Devices › Syringes & needles · 3 Aug 2025 · 9 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #28 · Compounds › Retatrutide · 30 Jul 2025 · 8 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #45 · Access › Insurance & coverage · 15 Jul 2025 · 2 likes Post #44 answers the question as asked. The question underneath it is different. Reimbursement changes: a compound covered one year might not be the next. A formulary…
-
A field-by-field walk through a certificate of analysis Replied, post #4 · Analytics › COA interpretation · 13 Jul 2025 · 5 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. The step people…
-
Second pass at: How to ask a question when you cannot say why you are asking it Started this topic · Start Here › How to Ask · 9 Jul 2025 · 2 likes Second pass at: How to ask a question when you cannot say why you are asking it — setting out what I have, and where I think it stops being reliable. Checking my…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 2 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
An emergency department visit, described afterwards Replied, post #39 · Safety › Adverse events · 7 Jul 2025 · 23 likes Marking my uncertainty on emergency department visit explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
-
Asking about a compound your prescriber has not heard of Replied, post #77 · Clinical › Prescriber conversations · 26 Jun 2025 · 6 likes The most useful question anyone here has reported asking: what would make you change your mind about this?
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #11 · Analytics › HPLC & UHPLC · 23 Jun 2025 · 30 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #136 · Practice › Reconstitution · 15 Jun 2025 · 0 likes Coming back to post #134, because the follow-up matters more than the original answer. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Antibiotics and a course of something with delayed emptying Replied, post #56 · Practice › Interactions · 3 Jun 2025 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #37 · Compounds › Retatrutide · 6 May 2025 · 11 likes The confident answers on Retatrutide mass and identity and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
A well-designed study with a badly written abstract Replied, post #55 · Evidence › Study critique · 1 May 2025 · 16 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
-
Requesting a translation of an existing page Replied, post #12 · Documentation › Wiki requests · 26 Apr 2025 · 2 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #37 · Compounds › Repair & healing peptides · 22 Apr 2025 · 2 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
A page that has drifted out of date and needs a maintainer Replied, post #93 · Documentation › Wiki requests · 22 Apr 2025 · 2 likes Review cadence should be part of the proposal. A page about a fast-moving area needs a shorter cycle and somebody willing to honour it. Take the reasoning and check the…
-
Follow-up: Documentation that appears only after payment Replied, post #10 · Sourcing › Red flags · 20 Apr 2025 · 0 likes I changed my mind about Documentation after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #34 · Compounds › Tirzepatide · 3 Apr 2025 · 16 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #47 · Documentation › Doc review · 15 Mar 2025 · 8 likes Where content is lifted from a topic, attribution should be in the document rather than only in the review thread.
-
Consistent declarations and why they matter more than clever ones Replied, post #151 · Sourcing › Logistics · 9 Mar 2025 · 1 like Agreed on all of that, and I have nothing to add to it.
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #5 · Access › Pricing · 11 Feb 2025 · 14 likes A note on how Manufacturer assistance programmes gets discussed rather than on Manufacturer assistance programmes itself: the confident posts get the replies and the…
-
An orphaned page with no inbound links Replied, post #3 · Meta › Wiki maintenance · 23 Jan 2025 · 0 likes The opening post describes the usual case. This is about the unusual one. Fair — and in this case it can, because it contains a number. So: one owner, two links. The…
-
Semaglutide in people without diabetes: what the evidence base looks like Replied, post #6 · Compounds › Semaglutide · 23 Jan 2025 · 0 likes This follows post #4 rather than contradicting it. Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported on kidney endpoints in…
-
[2026 update] New subcategory: rationale and scope Replied, post #123 · Meta › Announcements · 5 Jan 2025 · 0 likes Post #120 answers the question as asked. The question underneath it is different. On New subcategory: the maintained page in the documentation commons covers the…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #58 · Compounds › Oral incretins · 27 Dec 2024 · 3 likes Two questions I would want answered before drawing anything from the Oral semaglutide bioavailability data above: how were the cases selected, and what happened to the…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #25 · Analytics › Mass spectrometry · 25 Dec 2024 · 23 likes The arithmetic in post #22 is right; the assumption feeding it is the part to check. What mass accuracy establishes: the measured mass is consistent with a specific…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #10 · Sourcing › Vendor reports · 2 Dec 2024 · 0 likes Thank you — that answers what I came here to find out.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #77 · Analytics › Method validation · 20 Nov 2024 · 31 likes Post #76 is the version of this I will quote in future. One addition. An independent laboratory's method being different from the supplier's is not a discrepancy. It…
-
US compounding rules and how they changed Replied, post #65 · Regional › North America · 9 Nov 2024 · 10 likes Where I part company with post #63, and it is a narrow parting. Formulary position changes on a schedule that is published in advance, which means a decision made now…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #91 · Clinical › Bloodwork · 8 Oct 2024 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Pen wastage and its effect on real cost Replied, post #27 · Access › Pricing · 21 Sep 2024 · 0 likes The cost of an independent submission is worth stating in these threads, because it is the main reason people do not do it.
-
Correlation in a self-tracked dataset: what it can support Replied, post #147 · Research Methods › Statistics · 25 Aug 2024 · 0 likes Multiple testing inflates the false-positive rate in a way that is entirely predictable and entirely correctable. The correction should be declared in advance. The…
-
Guidelines revision: what changed and why Replied, post #111 · Meta › Announcements · 28 Jul 2024 · 23 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #34 · Practice › Dosing & titration · 26 Jul 2024 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
The mass-error checker and its intended scope Replied, post #150 · Data & Tools › Calculators · 24 Jul 2024 · 16 likes The reason mass-error checker keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.